Log in to search using one of your social media accounts:

 

Antibody Therapy Targets Cancer Stem Cells: Study
CT16 appears to eliminate cancer stem cells more effectively than radiation therapy in vitro and has shown promise in mice. (Source: The Scientist)
Source: The Scientist - March 15, 2017 Category: Science Tags: The Scientist, News & Opinion Source Type: news

Is Radiation Therapy Overused in Breast Cancer Care?
Title: Is Radiation Therapy Overused in Breast Cancer Care?Category: Health NewsCreated: 3/14/2017 12:00:00 AMLast Editorial Review: 3/15/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 15, 2017 Category: Cancer & Oncology Source Type: news

Glioblastoma clinical trial shows combined therapy extends life for patients 65 and older
(University Health Network) Treating older patients who have malignant brain cancer with the chemotherapy drug temozolomide plus a short course of radiation therapy extends survival by two months compared to treating with radiation alone, show clinical trial results published in the New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 15, 2017 Category: Cancer & Oncology Source Type: news

Reducing radiation could safely cut breast cancer treatment costs
More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 14, 2017 Category: Science Source Type: news

Is Radiation Therapy Overused in Breast Cancer Care?
Shorter course less expensive, equally effective in certain patients, researchers say (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 14, 2017 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Gynecology, Oncology, News, Source Type: news

Is Radiation Therapy Overused in Breast Cancer Care?
TUESDAY, March 14, 2017 -- More than half of older American women with early breast cancer may get more radiation therapy than needed, which significantly boosts medical costs, a new study indicates. Analyzing 2011 data on breast cancer patients,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 14, 2017 Category: Journals (General) Source Type: news

Reducing radiation could safely cut breast cancer treatment costs
(Duke University Medical Center) Over half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 14, 2017 Category: Cancer & Oncology Source Type: news

Is Radiation Therapy Overused in Breast Cancer Care?
Shorter course less expensive, equally effective in certain patients, researchers say (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - March 14, 2017 Category: Cancer & Oncology Source Type: news

OraCoat ® XyliMelts® Reduce Dry Mouth for Oral Cancer Patients
All-Natural Dry Mouth Remedy Can Help Reduce Xerostomia in Oral Cancer Patients Undergoing Chemo and Radiation Therapy TreatmentsBellevue, WA (March 6, 2017) –OraCoat®XyliMelts® help oral cancer patients suffering from dry mouth as a result of chemotherapy and radiation treatments.Xerostomia, more commonly known as dry mouth, is the subjective sensation of dryness experienced when an insufficient amount of saliva is produced. While mild or occasional oral dryness occurring especially during sleep is considered normal in healthy individuals, excessive ongoing dryness leads to, among other things, disturbed sle...
Source: Dental Technology Blog - March 13, 2017 Category: Dentistry Source Type: news

Challenge of Breast Reconstruction in Patients Undergoing Radiotherapy
Timing remains an important challenge for breast reconstruction in patients undergoing radiation therapy and surgery for breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 10, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Breast Cancer Conferences/MBCC 2017 News Source Type: news

Whole Brain Radiotherapy no ‘Magic Bullet’ for Breast Cancer CNS Metastases
Recent findings have raised doubts about the promise of whole brain radiation therapy against metastatic brain tumors for patients with advanced breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 10, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Breast Cancer Conferences/MBCC 2017 News Source Type: news

Whole-Brain Radiotherapy No ‘Magic Bullet’ for Breast Cancer CNS Metastases
Recent findings have raised doubts about the promise of whole-brain radiation therapy against metastatic brain tumors for patients with advanced breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 10, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Breast Cancer Conferences/MBCC 2017 News Source Type: news

iCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System
NASHUA, N.H. and MIAMI, March 9, 2017 -- (Healthcare Sales & Marketing Network) -- (Booth #T6) - iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatmen... Devices, Oncology iCAD , Xoft, IORT, radiotherapy, brachytherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 9, 2017 Category: Pharmaceuticals Source Type: news

Complexity of Cases, RT Treatment Delivery Drive Risk of Safety Incidents
A study found that several disease- and treatment-specific factors are associated with an increased risk of near misses or safety incidents in patients undergoing radiation therapy. (Source: CancerNetwork)
Source: CancerNetwork - March 7, 2017 Category: Cancer & Oncology Authors: Cancer Network Staff Tags: Cancer Complications News Practice & Policy Radiation Oncology Source Type: news

American Shared Hospital Services Announces Contract to Supply a Gamma Knife Perfexion System to Bryan Medical Center
SAN FRANCISCO--(Healthcare Sales & Marketing Network)--AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into ... Devices, Oncology, Neurosurgery American Shared Hospital Services, Elekta, Gamma Knife, Perfexion, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2017 Category: Pharmaceuticals Source Type: news

Decline in second cancer among childhood survivors
A new study by St Jude Children's Research Hospital has found that childhood cancer survivors have fewer occurrences of a second cancer thanks to a decrease in the use of radiation therapy. (Source: the Mail online | Health)
Source: the Mail online | Health - February 28, 2017 Category: Consumer Health News Source Type: news

Long-Term Data Confirm CRT Benefit in Muscle-Invasive Bladder Cancer
Long-term data from the phase III BC2001 trial confirmed that adding chemotherapy to radiation therapy improves locoregional control and reduces the rate of salvage cystectomy in patients with muscle-invasive bladder cancer. (Source: CancerNetwork)
Source: CancerNetwork - February 28, 2017 Category: Cancer & Oncology Authors: Ian Ingram Tags: Bladder Cancer Genitourinary Cancers News Radiation Oncology Source Type: news

As radiation therapy declined so did second cancers in childhood cancer survivors
(St. Jude Children's Research Hospital) Childhood cancer survivors are living longer. Now research shows they are also less likely to develop second cancers while still young. The decline followed a sharp drop in the use of radiation therapy for treatment of childhood cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 28, 2017 Category: Cancer & Oncology Source Type: news

Guidelines for treating brain metastases should be overhauled, UCLA study finds
FINDINGSA study by UCLA researchers has found that the National Comprehensive Cancer Network ’s guidelines for doctors treating people with three or more brain metastases — cancer cells that have spread from a primary tumor located in a different part of the body — are inconsistent and should be updated.They also found that there is not enough data to determine which of the two main approaches for treating people that have between three and 10 brain metastases — stereotactic radiosurgery and whole brain radiotherapy — is more effective, although more doctors in an international survey said tha...
Source: UCLA Newsroom: Health Sciences - February 27, 2017 Category: Universities & Medical Training Source Type: news

ViewRay wins 510(k) for MRIdian Linac system, touts Q4, FY2016 prelim results
ViewRay (NSDQ:VRAY) today announced it won FDA 510(k) clearance for its MRIdian Linac system, and released its preliminary earnings for the 4th quarter and full fiscal year 2016. The newly cleared MRIdian Linac device replaces the cobalt it utilized with linear accelerator technology, the Cleveland, Ohio-based company said. “FDA clearance of the MRIdian Linac is a transformative milestone for ViewRay. We believe that availability of the world’s first commercial system to combine MRI for soft-tissue visualization and a compact linear accelerator will lead to a new standard of care in radiation onc...
Source: Mass Device - February 27, 2017 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Business/Financial News Food & Drug Administration (FDA) Imaging Regulatory/Compliance ViewRay Inc. Source Type: news

ViewRay lands FDA clearance for MRI linac
Image-guided radiation therapy developer ViewRay has received 510(k) clearance...Read more on AuntMinnie.comRelated Reading: ViewRay lands Japanese order ViewRay touts APBI study on MRIdian ViewRay sees drop in Q3 revenue ViewRay touts ASTRO talks on MRIdian technology ViewRay gets Chinese approval for MRIdian system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 27, 2017 Category: Radiology Source Type: news

Artifact reduction algorithm boosts utility of 4D CT
Four-dimensional CT images can improve radiation therapy planning in the upper...Read more on AuntMinnie.comRelated Reading: Cardiac implants may be safer in MRI than thought Machine learning in radiology targets efficiency CT better than echo for aortic annulus before TAVR Researchers enhance holographic displays Top 5 trends from RSNA 2015 in Chicago (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 27, 2017 Category: Radiology Source Type: news

Augmenix touts more SpaceOar data
Augmenix touted data today from a Phase III trial evaluating its SpaceOar hydrogel in men undergoing prostate radiotherapy. The study showed that the company’s device, placed between the prostate and rectum, helps men maintain sexual function and potency following radiation therapy. Data from the trial demonstrated that the SpaceOar device reduced the median radiation dose to the penile bulb by 49%. Men treated with the system were also better able to maintain erections after 3 years compared to those in the control arm. “Loss of sexual function represents one of the most devastating consequences of radiation t...
Source: Mass Device - February 24, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Urology Augmenix Inc. Source Type: news

Expert calls for shorter radiation use in prostate cancer treatment
Men with prostate cancer can receive shorter courses of radiation therapy than what is currently considered standard, according to scientists. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 21, 2017 Category: Science Source Type: news

Penn expert calls for shorter radiation use in prostate cancer treatment
(University of Pennsylvania School of Medicine) Men with prostate cancer can receive shorter courses of radiation therapy than what is currently considered standard, according to Justin Bekelman, M.D., an associate professor of Radiation Oncology, Medical Ethics, and Health Policy at the University of Pennsylvania's Perelman School of Medicine and Abramson Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2017 Category: Cancer & Oncology Source Type: news

Cancer researchers to convene for Multidisciplinary Thoracic Cancers Symposium in March
(American Society for Radiation Oncology) The 2017 Multidisciplinary Thoracic Cancers Symposium, co-sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO) and The Society of Thoracic Surgeons (STS), will feature advances in surgery, radiation therapy, chemotherapy and novel molecular biologic therapies for thoracic malignancies such as lung cancer. The symposium will be held March 16-18, 2017, at the San Francisco Marriott Marquis. Press registration for the meeting is available online. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 16, 2017 Category: Global & Universal Source Type: news

FDA expands indication for Medtronic ’ s OsteoCool
Medtronic (NYSE:MDT) said today that it won an expanded indication from the FDA for its OsteoCool RF ablation device for palliative treatment of metastases in all bony anatomy. The OsteoCool RF device was previously indicated for use in the spine, according to Fridley, Minn.-based Medtronic. It’s used to ablate metastatic bone tumors. Medtronic acquired the technology when it bought Baylis Medical for an undisclosed amount back in December 2015. The original OsteoCool device 1st won 510(k) clearance in March 2012. A 2nd version landed another 510(k) in June 2015, and Montreal-based Baylis won a nod in ...
Source: Mass Device - February 15, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Oncology Orthopedics Baylis Medical Medtronic Source Type: news

South Jersey health system to build $6.9M radiation therapy center in Gloucester County
Inspira Health Network said Tuesday it will open a $6.9 million radiation therapy center for cancer patients at its Woodbury campus in Gloucester County next year. The 6,000-square-foot facility will, according to the South Jersey Health System, feature the SmartVue Natural Light Window, which are designed to eliminate the claustrophobic confines of the typical linear accelerator treatment room. The SmartVue window allows natural light directly into the room , providing patients with a view of an… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 14, 2017 Category: Pharmaceuticals Authors: John George Source Type: news

South Jersey health system to build $6.9M radiation therapy center in Gloucester County
Inspira Health Network said Tuesday it will open a $6.9 million radiation therapy center for cancer patients at its Woodbury campus in Gloucester County next year. The 6,000-square-foot facility will, according to the South Jersey Health System, feature the SmartVue Natural Light Window, which are designed to eliminate the claustrophobic confines of the typical linear accelerator treatment room. The SmartVue window allows natural light directly into the room , providing patients with a view of an… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2017 Category: Biotechnology Authors: John George Source Type: news

Radiation therapy continues to be gold standard for palliative care of painful bone metastases
An updated clinical guideline has been published that underscores the safety and effectiveness of palliative radiation therapy (RT) for treating painful bone metastases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 14, 2017 Category: Science Source Type: news

Radiation therapy continues to be gold standard to palliate painful bone metastases
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) recently published an updated clinical guideline that underscores the safety and effectiveness of palliative radiation therapy (RT) for treating painful bone metastases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 14, 2017 Category: Cancer & Oncology Source Type: news

Living With Cancer: Caring for your skin
How to care for skin during and after radiation Skin changes can be one of the primary side effects of radiation therapy. In addition to using a mild, unscented moisturizer, try these tips to feel more comfortable. Breast reconstruction with implants: An overview After a mastectomy, how does a plastic surgeon restore shape to a [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 9, 2017 Category: Databases & Libraries Source Type: news

Accuray wins Japanese regulatory nod for Radixact platform
Accuray (NSDQ:ARAY) said today it won approval from the Japanese Ministry of Health, Labor and Welfare for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments designed for cancer patients. Clearances include the Radixact treatment delivery system, Accuray Precision treatment planning system and iDMS data management system, the Sunnyvale, Calif.-based company said. “The approval of the Radixact System represents a key milestone in our strategic growth plans for the Japanese market. We are seeing positive momentum in the adoption of the Radixact System as clinicians become aw...
Source: Mass Device - February 8, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Oncology Regulatory/Compliance Accuray Inc. Source Type: news

Antiandrogen With Salvage RT Can Prolong Survival in Prostate Cancer
A long-term study found that adding 24 months of antiandrogen therapy with bicalutamide to salvage radiation therapy increased overall survival and prostate cancer –specific survival compared with placebo in men who underwent radical prostatectomy. (Source: CancerNetwork)
Source: CancerNetwork - February 8, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Genitourinary Cancers News Prostate Cancer Source Type: news

Breast Conserving Surgery Plus RT Better Than Mastectomy in Some Patients
A large registry study found that certain breast cancer patients gain a significant survival benefit with breast conserving surgery plus radiation therapy compared with mastectomy (Source: CancerNetwork)
Source: CancerNetwork - February 7, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news

Mayo Clinic Q and A: Proton beam therapy may be recommended for some types of cancer
DEAR MAYO CLINIC: My mother recently was diagnosed with breast cancer, and her doctor told her regular radiation wasn?t as safe as proton beam therapy for her situation. Why would this be the case? I know lots of women who have had radiation for breast cancer treatment. ANSWER: It?s true that standard radiation therapy?often is [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 3, 2017 Category: Databases & Libraries Source Type: news

Adding antiandrogen to radiation therapy improves survival in recurrent prostate cancer
(Massachusetts General Hospital) A nearly two-decades-long clinical trial has demonstrated that adding antiandrogen therapy to radiation therapy can improve the survival of prostate cancer patients who have evidence of disease recurrence after radical prostatectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2017 Category: Cancer & Oncology Source Type: news

Twice-daily radiation therapy cuts deaths from head and neck cancer
(ECCO-the European CanCer Organisation) Treating head and neck cancer patients with a twice-daily radiation therapy combined with chemotherapy could save more lives. By splitting the daily treatment in two portions, a higher and more effective dose can be given to patients, according to research presented at the European Cancer Congress 2017. The researchers hope that this can be achieved without increasing side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 26, 2017 Category: Cancer & Oncology Source Type: news

We've Been Seriously Underestimating Cervical Cancer Risks
Women, especially black women, might face a greater chance of dying of cervical cancer than previously thought, according to a study published Monday in the journal Cancer. Estimates from previous studies may have been artificially low because they included women who had had hysterectomies, a procedure to remove the uterus. The new study suggests that black women are dying at a rate 77 percent higher, and white women are dying at a rate 47 percent higher, than researchers had previously thought. After adjusting for hysterectomies, cervical cancer killed 10 out of every 100,000 black women and approximately 5 out ...
Source: Healthy Living - The Huffington Post - January 24, 2017 Category: Consumer Health News Source Type: news

Unraveling mysteries of pancreatic cancer's resistance to standard therapies
In a new study, researchers have illuminated one of pancreatic cancer's major resistance mechanisms: a form of inflammation that is triggered by the tumor in response to treatment and helps keep tumor cells alive. Blocking this inflammation after radiation therapy brought a significant improvement in survival in a mouse model of the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 24, 2017 Category: Science Source Type: news

Penn researchers help unravel mysteries of pancreatic cancer's resistance to standard therapies
(University of Pennsylvania School of Medicine) In a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania have illuminated one of pancreatic cancer's major resistance mechanisms: a form of inflammation that is triggered by the tumor in response to treatment and helps keep tumor cells alive. Blocking this inflammation after radiation therapy brought a significant improvement in survival in a mouse model of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 24, 2017 Category: Cancer & Oncology Source Type: news

SBRT Equivalent to TACE as Bridge to Transplant for Patients With HCC
Use of stereotactic body radiation therapy (SBRT) was equally effective as transarterial chemoembolization (TACE) as a method of bridge to transplant among patients with hepatocellular carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - January 22, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASCO 2017 Gastrointestinal Cancers Symposium Liver, Gallbladder, and Biliary Tract Cancers News Source Type: news

Surrogate Endpoints Useful in Study of Treatments for Prostate Cancer
In prostate cancer patients, a PSA nadir value of> 0.5 ng/mL after radiation therapy and androgen deprivation therapy can identify patients at a high risk of death. (Source: CancerNetwork)
Source: CancerNetwork - January 21, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Genitourinary Cancers News Prostate Cancer Source Type: news

Many with Advanced Lung Cancer Don't Get Treatments That Might Help
Study found 21 percent went without therapy, even though it could boost their survival Source: HealthDay Related MedlinePlus Pages: Cancer Chemotherapy, Lung Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 20, 2017 Category: Consumer Health News Source Type: news

Medtec Report: China increases focus on med device development
Regulators in China are looking to promote and increase the localization and development of medical devices in the region and grow the market significantly, according to a report from industry group Medtec. China released its 13th 5-year health strategy plan, drawing a bead on medical devices as a “main breakthrough area” for the country, according to the report. The country is entering a “policy-intensive promotional period,” according to the medtech advocacy group, looking to support the development of high-performance medical equipment including medical imaging devices, advanced radiation th...
Source: Mass Device - January 19, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News MedTech Source Type: news

ViewRay brings in $26m from private placement
ViewRay (NSDQ:VRAY) said today it raised $26.1 million in a private placement of common stock and warrants to support the ongoing commercialization of its MRIdian linear accelerator tech. In the placement, Cleveland-based ViewRay said it sold approximately 8.6 million shares of common stocks with warrants to purchase an additional 1.7 million shares, with an exercise prise of $3.17. The round was led by Puissance Capital Management and joined by existing investors including OrbiMed Advisors, Kearny Venture Partners and new investor Acuta Capital Partners. As part of the placement round, Puissance Capital Management ch...
Source: Mass Device - January 19, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News ViewRay Inc. Source Type: news

TGen identifies compound that could improve drug development against deadly brain cancer
(The Translational Genomics Research Institute) A study led by scientists at TGen has identified 'a potent inhibitory compound' in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly type of adult brain cancer. Aurintricarboxylic Acid (ATA) is a chemical compound that in laboratory tests was shown to block the chemical cascade that otherwise allows glioblastoma cells to invade normal brain tissue and resist both chemo and radiation therapy, according to a TGen-led report published today in the scientific journal Oncotarget. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2017 Category: Cancer & Oncology Source Type: news

Augmenix touts study on prostate treatment
Prostate radiation therapy device developer Augmenix is highlighting the results...Read more on AuntMinnie.comRelated Reading: Augmenix gets FDA clearance for tissue marker (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2017 Category: Radiology Source Type: news